# Dose-ranging Study of SKF7™ for Obesity

> **NCT04557267** · PHASE2 · COMPLETED · sponsor: **Indonesia University** · enrollment: 160 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** low-dose
- **DRUG:** Middle-dose
- **DRUG:** Higher-dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04557267
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-30
- **Primary completion:** 2021-05-20
- **Final completion:** 2021-05-22
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2021-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04557267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04557267, "Dose-ranging Study of SKF7™ for Obesity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04557267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*